Brian E. Mcdowell

Array ( [id] => 6618924 [patent_doc_number] => 20100099871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'ANTI-PSYCHOTIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS\nTHEREOF' [patent_app_type] => utility [patent_app_number] => 12/542556 [patent_app_country] => US [patent_app_date] => 2009-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17287 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099871.pdf [firstpage_image] =>[orig_patent_app_number] => 12542556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6329627 [patent_doc_number] => 20100197915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'LAPATINIB INTERMEDIATES' [patent_app_type] => utility [patent_app_number] => 12/536972 [patent_app_country] => US [patent_app_date] => 2009-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9914 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197915.pdf [firstpage_image] =>[orig_patent_app_number] => 12536972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6083874 [patent_doc_number] => 20110144084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => '6 SUBSTITUTED 2- HETEROCYCLYLAMINO PYRAZINE COMPOUNDS AS CHK-1 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/057558 [patent_app_country] => US [patent_app_date] => 2009-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 92135 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20110144084.pdf [firstpage_image] =>[orig_patent_app_number] => 13057558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8174203 [patent_doc_number] => 20120108817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'ACETYL PYRROLIDINYL INDOLE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 13/058626 [patent_app_country] => US [patent_app_date] => 2009-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13202 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20120108817.pdf [firstpage_image] =>[orig_patent_app_number] => 13058626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8797131 [patent_doc_number] => 08436000 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-07 [patent_title] => 'Substituted carbamate derivatives as modulators of corticotropin-releasing factor receptor activity' [patent_app_type] => utility [patent_app_number] => 13/055885 [patent_app_country] => US [patent_app_date] => 2009-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13851 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13055885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6144374 [patent_doc_number] => 20110130286 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'Piperazine Compounds with Herbicidal Effect' [patent_app_type] => utility [patent_app_number] => 13/056320 [patent_app_country] => US [patent_app_date] => 2009-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 75105 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20110130286.pdf [firstpage_image] =>[orig_patent_app_number] => 13056320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6144784 [patent_doc_number] => 20110130409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'SUBSTITUTED 1,2,3,4-TETRAHYDROCYCLOPENTA[B]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/055333 [patent_app_country] => US [patent_app_date] => 2009-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 50092 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20110130409.pdf [firstpage_image] =>[orig_patent_app_number] => 13055333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6509376 [patent_doc_number] => 20100210686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN' [patent_app_type] => utility [patent_app_number] => 12/506040 [patent_app_country] => US [patent_app_date] => 2009-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52906 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210686.pdf [firstpage_image] =>[orig_patent_app_number] => 12506040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7997615 [patent_doc_number] => 08080655 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-20 [patent_title] => 'Methods of making efavirenz and intermediates thereof' [patent_app_type] => utility [patent_app_number] => 12/505627 [patent_app_country] => US [patent_app_date] => 2009-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9455 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/080/08080655.pdf [firstpage_image] =>[orig_patent_app_number] => 12505627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6178589 [patent_doc_number] => 20110178302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'NUCLEOPHILIC FLUORINATION OF AROMATIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/054458 [patent_app_country] => US [patent_app_date] => 2009-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 13956 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20110178302.pdf [firstpage_image] =>[orig_patent_app_number] => 13054458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6447510 [patent_doc_number] => 20100105095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'Optical Molecular Sensors for Cytochrome P450 Activity' [patent_app_type] => utility [patent_app_number] => 12/499047 [patent_app_country] => US [patent_app_date] => 2009-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 27294 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105095.pdf [firstpage_image] =>[orig_patent_app_number] => 12499047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7740639 [patent_doc_number] => 08106043 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => 'Benzoxazines, benzothiazines, and related compounds having NOS inhibitory activity' [patent_app_type] => utility [patent_app_number] => 12/498185 [patent_app_country] => US [patent_app_date] => 2009-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 64454 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/106/08106043.pdf [firstpage_image] =>[orig_patent_app_number] => 12498185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5558764 [patent_doc_number] => 20090270341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'PRODUCT COMPRISING A TRANSDUCTION INHIBITOR OF HETEROTRIMERIC G PROTEIN SIGNALS COMBINED WITH ANOTHER ANTI-CANCER AGENT FOR THERAPEUTIC USE IN THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/496896 [patent_app_country] => US [patent_app_date] => 2009-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6088 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270341.pdf [firstpage_image] =>[orig_patent_app_number] => 12496896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6631769 [patent_doc_number] => 20100004448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'METHODS OF PREPARING QUINAZOLINONE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/490877 [patent_app_country] => US [patent_app_date] => 2009-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4749 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004448.pdf [firstpage_image] =>[orig_patent_app_number] => 12490877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8233013 [patent_doc_number] => 08198441 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-12 [patent_title] => 'Process for the preparation of novel pyridopyrazines as mTOR kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/487294 [patent_app_country] => US [patent_app_date] => 2009-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 38838 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/198/08198441.pdf [firstpage_image] =>[orig_patent_app_number] => 12487294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4524248 [patent_doc_number] => 07951814 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-31 [patent_title] => 'Quinazolinedione derivatives as TRPA1 modulators' [patent_app_type] => utility [patent_app_number] => 12/485600 [patent_app_country] => US [patent_app_date] => 2009-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 35026 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/951/07951814.pdf [firstpage_image] =>[orig_patent_app_number] => 12485600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5398625 [patent_doc_number] => 20090318688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'METHOD FOR PREPARING PHENYLALANINE DERIVATIVES HAVING QUINAZOLINE-DIONE SKELETON AND INTERMEDIATES FOR USE IN THE PREPARATION OF DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/470846 [patent_app_country] => US [patent_app_date] => 2009-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26920 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318688.pdf [firstpage_image] =>[orig_patent_app_number] => 12470846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5404560 [patent_doc_number] => 20090239874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'Pyrido[3,2-e]pyrazines, their use as inhibitors of phospohodiesterase 10, and processes for preparing them' [patent_app_type] => utility [patent_app_number] => 12/454537 [patent_app_country] => US [patent_app_date] => 2009-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16254 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239874.pdf [firstpage_image] =>[orig_patent_app_number] => 12454537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6237513 [patent_doc_number] => 20100267949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'Method of Synthesizing 6,7-Substituted 4-Anilino Quinazoline' [patent_app_type] => utility [patent_app_number] => 12/464868 [patent_app_country] => US [patent_app_date] => 2009-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6131 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267949.pdf [firstpage_image] =>[orig_patent_app_number] => 12464868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7703028 [patent_doc_number] => 08088782 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-03 [patent_title] => 'Crystalline 4-(3-chloro-2-fluoroanilino)-7 methoxy-6-{[1-(N-methylcarbamoylmethyl)piperidin-4-yl]oxy}quinazoline difumarate form A' [patent_app_type] => utility [patent_app_number] => 12/463624 [patent_app_country] => US [patent_app_date] => 2009-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 24 [patent_no_of_words] => 23103 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/088/08088782.pdf [firstpage_image] =>[orig_patent_app_number] => 12463624 [rel_patent_id] =>[rel_patent_doc_number] =>)